Mazen Dimachkie, MD
Enriched profileProfessor of Neurology and Director, Neuromuscular Division; Executive Vice Chairman, Department of Neurology · University of Kansas Medical Center
Mazen Dimachkie is Professor of Neurology and Director, Neuromuscular Division; Executive Vice Chairman, Department of Neurology at University of Kansas Medical Center. OpenAlex indexes 428 publications with 14,433 citations (h-index 61); ClinicalTrials.gov lists 10 registered studies with this person as an investigator.
Data verified 8 Oct 2026
Overview
Updated 14 Oct 2026
Mazen Dimachkie, M.D., is Professor of Neurology and Director, Neuromuscular Division at University of Kansas Medical Center. The public record shows 428 publications with 14,433 citations (h-index 61), centered on Peripheral Neuropathies and Disorders, Inflammatory Myopathies and Dermatomyositis, Myasthenia Gravis and Thymoma. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 27 companies, 1 NIH-funded awards (2015–2020).
- Top research focus: Peripheral Neuropathies and Disorders
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 27 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 166.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time
Sponsor: University of Kansas Medical Center
- Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
Sponsor: University of Kansas Medical Center
Industry payments
Updated 14 Oct 2026
27 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Octapharma USA, Inc.Program year20252 payments$52,375openpaymentsdata.cms.gov ↗
- UCB SAProgram year20251 payment
- Amicus Therapeutics, Inc.Program year20251 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
48.7%Cholinesterase Inhibitor17.9%Pyridostigmine Bromide100%Part D≥19 patientsGabapentinoids17.2%Gabapentin82%Pregabalin18%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
32.4%Corticosteroid32.4%Prednisone100%Part D≥28 patientsCancer & immunology
9.7%Complement Inhibitor6.5%Ultomiris52%Soliris48%Part D<11 patientsPurine Antimetabolite3.1%Azathioprine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
1 NIH research award on record, funded 2015–2020 per NIH RePORTER. The latest:
- Digital Biomarkers of Motor Function as Drug Development Tools in Charcot-Marie-Tooth Disease
Biosensics, Llc
FY2026$1,100,000U01FD009005
Congress activity
Updated 14 Oct 2026
1 congress contribution (2019) across ADA per OpenAlex. The most recent:
- 2269-PUB: Early Attrition from a Randomized Lifestyle Modification Protocol
ADA Scientific Sessions
ADA2019Co-authorOnline-only
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study
Proceedings of the National Academy of Sciences
2022
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03
- 04Guillain-Barré Syndrome and VariantsArticle378 citations2013
- 05Regional variation of Guillain-Barré syndromeArticle341 citations2018
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 14 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
understandingmyositis.org/update-arimoclomol-sibm
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →understandingmyositis.org ↗ - Other
myositis.org/wp-content/uploads/2023/11/October-2023-Newsletter.pdf
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →myositis.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
American University of Beirut
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗ - BS in Chemistry with Distinction
American University of Beirut
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗ - Board certified in Neurology
Clinical Neurophysiology and Neuromuscular Medicine (ABPN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗
Editorial & leadership roles
journal and society appointments- Fellow
American Academy of Neurology (FAAN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗ - Fellow
American Neurological Association (FANA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗ - Medical Advisory Board Member
Myasthenia Gravis Foundation of America
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗
Secondary affiliations
appointments beyond the home institution- Associate Director
Institute for Neurological Discoveries, University of Kansas Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗ - Director
Neuromuscular Medicine Fellowship, University of Kansas Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kumc.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Mario Castro, MD
University of Kansas Medical Center
Jeffrey Burns, MD
University of Kansas Medical Center
Carol Fabian, MD
University of Kansas Medical Center
Matthias Salathe, MD
University of Kansas Medical Center
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida